<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04859933</url>
  </required_header>
  <id_info>
    <org_study_id>HDZ_ER_003_GI</org_study_id>
    <nct_id>NCT04859933</nct_id>
  </id_info>
  <brief_title>AV Node Isolation in Atrial Fibrillation vs. Modulation by &quot;Pace and Ablate&quot; Strategy</brief_title>
  <official_title>AV Node Isolation in Atrial Fibrillation vs. Modulation by &quot;Pace and Ablate&quot; Strategy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heart and Diabetes Center North-Rhine Westfalia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heart and Diabetes Center North-Rhine Westfalia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      AV-node ablation (AVNA) is a common therapy option for rate control strategy of permanent&#xD;
      atrial fibrillation with numerous side effects. The investigators hypothesised that an&#xD;
      isolation of the AV node is concomitant with less occurrence of new bundle brunch blocks,&#xD;
      more frequent preservation and higher rate of escape rhythm compared to AVNA. This&#xD;
      retrospective study includes 20 patients being treated with AV-node isolation (AVNI) and 40&#xD;
      historical AVNA-controls. Among others these two methods were compared regarding escape&#xD;
      rhythm, delta QRS, procedure time, ablation points, fluoroscopy time and total dose area&#xD;
      product (DAP).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>AV-node escape rhythm</measure>
    <time_frame>intraoperative, follow-up after 1 to 3 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>bundle branch blocks</measure>
    <time_frame>intraoperative, follow-up after 1 to 3 month</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>AV Node Ablation</condition>
  <condition>Escape; Rhythm</condition>
  <arm_group>
    <arm_group_label>AVNA group</arm_group_label>
    <description>Group of historical controls beeing treated with AV-node ablation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AVNI group</arm_group_label>
    <description>Inculudes all patients beeing treated with AV-node isolation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>AV-node isolation</intervention_name>
    <description>Abaltion performed in the right atrium isolating the AV-node from the atrium</description>
    <arm_group_label>AVNI group</arm_group_label>
    <other_name>AVNI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>AV-node ablation</intervention_name>
    <description>Right sided ablation of the AV-node</description>
    <arm_group_label>AVNA group</arm_group_label>
    <other_name>AVNA</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to Heart- and Diabetes Centre NRW for AV-node ablation/isolation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  paroxysmal, persistend or permanent atrial fibrillation; indication for AVNA&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  other indications for AVNA than atrial fibrillation as AVNRT, atrial flutter, atrial&#xD;
             tachycardia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Guram Imnadze, MD</last_name>
    <phone>495731971327</phone>
    <email>gimnadze@hdz-nrw.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Astrid Kleemeyer</last_name>
    <phone>49 5731 971258</phone>
    <email>akleemeyer@hdz-nrw.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Herz- und Diabeteszentrum NRW, Ruhr-Universit√§t Bochum</name>
      <address>
        <city>Bad Oeynhausen</city>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guram Imnadze, MD</last_name>
      <phone>0495731971327</phone>
      <email>gimnadze@hdz-nrw.de</email>
    </contact>
    <contact_backup>
      <last_name>Astrid Kleemeyer</last_name>
      <phone>0495731971258</phone>
      <email>akleemeyer@hdz-nrw.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 22, 2021</study_first_submitted>
  <study_first_submitted_qc>April 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2021</study_first_posted>
  <last_update_submitted>May 3, 2021</last_update_submitted>
  <last_update_submitted_qc>May 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

